Onyx Biotec Limited was founded in May 2005. The company is active in the healthcare industry and offers sterile pharmaceutical products. It has emerged as a major supplier of sterile products to major companies including the leading pharmaceutical companies across India. Onyx strives to provide high quality products at an affordable price.

The company manufactures sterile water for injections and acts as a pharmaceutical contract manufacturer offering a comprehensive range of dry powder injections and dry syrup for India and overseas. The products are processed and manufactured in accordance with global FDA best practices.

Onyx Biotec IPO, a SME IPO of ₹29.34 Cr opens for subscription from 13-11-2024 to 18-11-2024. The IPO consists of ₹29.34 Cr fresh issue. The face value is Rs. 10 and the price band is fixed at 58.00-61.00 per share. You can apply to the Onyx Biotec SME IPO for a minimum lot of 2000 shares amounting of Rs. 122000. The tentative listing date on the exchange (NSE SME) is 21-11-2024.

Onyx Biotec Services IPO Details

IPO Open DateNovember 13, 2024
IPO Close DateNovember 18, 2024
Face Value₹10 Per Equity Share
IPO Price Band₹58 to ₹61 Per Share
Issue SizeApprox ₹29.34 Crores
Fresh IssueApprox ₹29.34 Crores
Issue TypeBook Built Issue
IPO ListingNSE SME
Retail QuotaNot more than 35%
QIB QuotaNot more than 50%
NII QuotaNot more than 15%

Onyx Biotec Services IPO Timeline

The Onyx Biotec Services IPO date is November 13 and the close date is November 18. The Onyx Biotec Services IPO allotment will be finalized on November 19 and the IPO listing on November 21.

IPO Open Date:November 13, 2024
IPO Close Date:November 18, 2024
Basis of Allotment:November 19, 2024
Refunds:November 20, 2024
Credit to Demat Account:November 20, 2024
IPO Listing Date:November 21, 2024

Onyx Biotec SME IPO Lots

SME IPO ActivityDate
Issue Price₹58.00-61.00
Market Lot2000 Shares
1 Lot Amount₹122000
Min HNI Lots4000 shares (2 lots)- ₹244000

FY2024 Valuation Insights for Onyx Biotec Services IPO

Period Ended31 May 202431 Mar 202431 Mar 202331 Mar 2022
Assets7,476.577,413.585,872.363,683.84
Revenue1,054.115,387.433,961.654,498.09
Profit After Tax130.77303.16184.46335.29
Net Worth2,618.642,487.871,820.161,637.59
Reserves and Surplus1,286.421,155.651,230.001,047.43
Total Borrowing3,156.143,078.042,922.831,224.39

Categorized in:

IPO,

Last Update: November 13, 2024